QuidelOrtho (QDEL) Shares Soar 41.04% on Strong Q1 Earnings

QuidelOrtho (QDEL) shares surged 41.04% today, reaching their highest level since March 2025 with an intraday gain of 44.06%.

The strategy of buying QDEL shares after they reached a recent high and holding for 1 week yielded moderate returns over the past 5 years, with a 7.56% annualized return. This indicates a relatively conservative approach that captured some of the stock's volatility while preserving capital.

QuidelOrtho's stock price has been positively influenced by several recent developments. The company achieved a solid mid-single-digit revenue growth of 6% in Q1 2025, excluding COVID and donor screening, which indicates strong performance in other segments.

Jefferies upgraded QuidelOrtho's rating from "Hold" to "Buy," reflecting positive sentiment from analysts. This upgrade, along with the company's strong financial performance, has contributed to the rise in share price.

QuidelOrtho delivered adjusted earnings per share (EPS) of 74 cents in Q1 2025, up 68.2% year over year, and surpassing the Zacks Consensus Estimate of 58 cents per share. This earnings beat has further boosted investor confidence in the company.

Despite a decrease in total revenue related to COVID-19 and donor screening, QuidelOrtho maintained its full-year 2025 financial guidance, showcasing confidence in its overall financial health. This stability in guidance has also contributed to the positive sentiment surrounding the stock.